Urinary Incontinence in Old AgePROMOTENCT07243223
Urinary Incontinence in Older Hong Kong Women: A Cross-sectional Study
An observational study of Urinary Incontinence in Old Age, run by Hong Kong Baptist University.
Trial summary
This is a prospective, cross-sectional study aim to include 1000 patients with urinary incontinence and 100 healthy controls in Hong Kong. The overall objection is to address the gaps in epidemiological profiles, TCM syndrome differentiation, and biomarkers discovery of urinary incontinence among older women. Read more about this study
- Who is it for?
- Ages 55 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Urinary Incontinence in Old Age
- How many people
- 1,100 participants
- Where
- No sites listed yet
- Study dates
- 30 Nov 2025to 1 Mar 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 55 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Study population: Urinary incontinence group: Aged ≥55 years; Has been living in Hong Kong for one year or more; Meet the diagnostic criteria for MUI, UUI, or MUI defined by the International Continence Society (ICS); Able to understand and use Chinese or English; Signed the informed consent form. Healthy group: Aged ≥55 years; Has been living in Hong Kong for one year or more; Never went through urinary incontinence and never consult the doctor for suspect urinary incontinence related symptoms; No chronic comorbidity (expect for well-controlled hypertension and hyperlipidemia); Not taking medications that affect urination or gut microbiota; Able to understand and use Chinese or English; Signed the informed consent form.
Diagnostic Criteria:
- Urinary Incontinence (UI):Urinary incontinence will be diagnosed according to the definition of the International Continence Society (ICS), that is, 'any involuntary leakage of urine'. In addition, participants must have experienced this symptom continuously for at least six months to exclude cases of transient urinary incontinence.
- Stress Urinary Incontinence (SUI):The clinical diagnosis of SUI will be made with reference to the guidelines of the European Association of Urology (EAU) and the International Continence Society (ICS):
- Symptoms: Involuntary leakage of urine during activities that increase intra-abdominal pressure, such as physical exertion, laughing, coughing, or walking; urine leakage stops immediately when the activity ceases.
- Signs: Positive result on the cough stress test or a positive 1-hour pad test (the procedure will follow the standardized ICS protocol; leakage >1g is considered positive).
- Pure urge incontinence and mixed urinary incontinence will be excluded. This subtype will be preliminarily identified using the Chinese version of the "3 Incontinence Questions" (3IQ): "During the past three months, in which of the following situations did you most often experience urine leakage? (single choice) A. During physical activities such as coughing, sneezing, lifting, or exercise; B. When you had the urge to urinate or felt the need to empty your bladder but could not reach the toilet in time; C. Without physical activity or urge; D. Equally during physical activity and urgency." (Selection of option A) SUI will be finally confirmed by a one-week bladder diary (showing only stress-related leakage) and a positive 1-hour pad test.
- Urge Urinary Incontinence (UUI):The clinical diagnosis of UUI will follow the guidelines of the European Association of Urology (EAU) and the International Continence Society (ICS):
- Symptoms: Involuntary leakage of urine accompanied by or immediately preceded by urgency (a sudden, compelling desire to void that is difficult to defer).
- Cases of pure stress urinary incontinence and mixed urinary incontinence will be excluded.
This subtype will be preliminarily identified using the Chinese version of the "3 Incontinence Questions" (3IQ): "During the past three months, in which of the following situations did you most often experience urine leakage? (single choice) A. During physical activities such as coughing, sneezing, lifting, or exercise; B. When you had the urge to urinate or felt the need to empty your bladder but could not reach the toilet in time; C. Without physical activity or urge; D. Equally during physical activity and urgency." (Selection of option B) Final confirmation will be based on a one-week bladder diary recorded by the participant (showing only urgency-related leakage).
- Mixed Urinary Incontinence (MUI):The clinical diagnosis of MUI will follow the guidelines of the European Association of Urology (EAU) and the International Continence Society (ICS):
- Symptoms: The presence of stress urinary incontinence symptoms, such as involuntary leakage of urine during activities that increase intra-abdominal pressure (e.g., exercise, laughing, coughing, walking), with urine flow ceasing immediately upon stopping the activity; and, at the same time, the presence of urge urinary incontinence symptoms, such as urgency (a sudden, compelling desire to void that is difficult to defer) accompanied by or immediately followed by involuntary leakage of urine.
- Signs: Positive result on the cough stress test or a positive 1-hour pad test (the procedure will follow the standardized protocol of the ICS; leakage >1g is considered positive).
- Cases of pure urge urinary incontinence and pure stress urinary incontinence will be excluded.
This subtype will be preliminarily identified using the Chinese version of the "3 Incontinence Questions" (3IQ): "During the past three months, in which of the following situations did you most often experience urine leakage? (single choice) A. During physical activities such as coughing, sneezing, lifting, or exercise; B. When you had the urge to urinate or felt the need to empty your bladder but could not reach the toilet in time; C. Without physical activity or urge; D. Equally during physical activity and urgency." (Selection of option D) Final confirmation will be based on a one-week bladder diary recorded by the participant (showing both urgency- and stress-related leakage) and a positive 1-hour pad test.
- Inclusion Criteria for Patients with Urinary Incontinence
- Females aged ≥55 years
- Has been living in Hong Kong for one year or more.
- Meet the diagnostic criteria for SUI, UUI, or MUI, and the symptoms of urinary incontinence have persisted for at least 6 months.
- Able to understand and follow written and verbal instructions in Chinese or English.
- Provide informed consent voluntarily after being fully informed
- Exclusion Criteria for Patients with Urinary Incontinence
- Diagnosed with types of urinary incontinence other than stress, urge, or mixed urinary incontinence, including those secondary to neurological or systemic diseases (such as post-stroke, post-spinal cord injury, multiple sclerosis, Alzheimer's disease, Parkinson's disease, or uncontrolled diabetic peripheral neuropathy), as well as the overflow incontinence.
- Active or structural urogenital diseases (such as unrepaired vesicoureteral reflux, congenital urethral malformations, urogenital fistula, urethral diverticulum, or active pelvic malignancies).
- Deemed by researchers to be unable to cooperate with assessments due to severe mental or physical illness.
- Eligible Urinary Incontinence Patients for Bio-Sample Collection
- The first 300 urinary incontinence patients (100 each with SUI, UUI, and MUI) enrolled in the study.
- No chronic comorbidities (except for well-controlled hypertension, defined as systolic blood pressure below 140 mmHg and diastolic blood pressure below 90 mmHg, and hyperlipidemia), including neurological disorders (central nervous system injury, motor neuron diseases, neurodegenerative diseases), diabetes, connective tissue diseases, psychiatric disorders, severe cardiovascular or cerebrovascular diseases, and severe liver or kidney diseases.
- Not using medications that affect urination or gut microbiota (including but not limited to thiazolidinediones, sodium-glucose cotransporter-2 inhibitors, anticholinergics, α- and β-adrenergic blockers, α- and β-adrenergic agonists, diuretic antihypertensives, antihistamines, muscarinic receptor antagonists, calcium channel blockers, angiotensin-converting enzyme inhibitors, hormone medications, neurotransmitter-related drugs, gut microbiota modulators, etc.).
- Inclusion Criteria for Healthy Volunteers
- Female, aged ≥55 years;
- Has been living in Hong Kong for one year or more;
- Able to understand and follow written and verbal instructions in Chinese or English;
- Fully informed and voluntarily signs the informed consent form.
- Exclusion Criteria for Healthy Volunteers
- Meet the diagnostic criteria for urinary incontinence;
- Has a history of involuntary urine leakage, or has sought medical consultation for symptoms related to urinary incontinence;
- Has chronic comorbidities (except for well-controlled hypertension, defined as systolic blood pressure below 140 mmHg and diastolic blood pressure below 90 mmHg, and hyperlipidemia).
- Uses medications that affect urination or gut microbiota (including but not limited to thiazolidinediones, sodium-glucose cotransporter-2 inhibitors, anticholinergics, α- and β-adrenergic blockers, α- and β-adrenergic agonists, diuretic antihypertensives, antihistamines, muscarinic receptor antagonists, calcium channel blockers, angiotensin-converting enzyme inhibitors, hormone medications, neurotransmitter-related drugs, and gut microbiota modulators, etc.).
- Deemed by researchers to be unable to cooperate with assessments due to severe mental or physical illness.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Epidemiological Profiles, Traditional Chinese Medicine Syndrome, and Biomarkers of Urinary Incontinence in Older Hong Kong Women: A Cross-sectional Study
This is a prospective, cross-sectional study aim to include 1000 patients with urinary incontinence and 100 healthy controls in Hong Kong. The overall objection is to address the gaps in epidemiological profiles, TCM syndrome differentiation, and biomarkers discovery of urinary incontinence among older women. The specific aims including:
- To assess the epidemiological characteristics of urinary incontinence among older women, as well as patients' knowledge and healthcare-seeking barriers, and to explore factors influencing the disease subtypes, severity, and healthcare-seeking behaviors;
- To establish diagnostic criteria for traditional Chinese medicine (TCM) syndrome differentiation of urinary incontinence, and analyze the distribution of TCM syndromes;
- To explore diagnostic biomarkers and severity evaluation biomarkers for three subtypes of urinary incontinence (SUI, UUI, MUI).
Read the detailed description
This study is a cross-sectional observational study designed in accordance with the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines. A total of 1,000 female patients with urinary incontinence and 100 healthy controls will be enrolled.
Both urinary incontinence group and healthy group will be recruited through a combination of online publicity (via social media platforms) and offline community outreach. Each participant will be scheduled for a visit, during which the research staff will introduce the study's objectives, procedures, nature, and data privacy policy. Informed consent will be obtained. Socio-epi-demographic information (including age, educational level, marital status, occupation, income, reproductive history, medical history, comorbidities, medication history, diagnosis and treatment for urinary incontinence) and the type, frequency and severity of lower urinary tract symptoms will be collected.
Then, eligible participants with symptoms of urinary incontinence will undergo a 1-hour pad test, bladder capacity and post-void residual volume measurements, and a 1-week bladder diary to confirm the subtype of urinary incontinence (SUI, MUI, UUI) and its severity (mild, moderate, severe). Standardized questionnaires will be administered to assess the cognitive level regarding urinary incontinence (UIQ), quality of life (IIQ-7 and ICIQ-UI-SF), and barriers to care seeking (Barriers to Incontinence Care Seeking Questionnaire). Hand grip strength test will be conducted to evaluate the muscle strength. The first 300 urinary incontinence patients (100 with SUI, 100 with UUI, and 100 with MUI) enrolled in the study, who do not have chronic comorbidities (except for well-controlled hypertension or hyperlipidemia) and are not taking medications that affect urination or gut microbiota, will proceed to TCM syndrome differentiation and bio-sample collection. TCM syndrome differentiation related symptoms and signs will be collected for Delphi consensus research and cluster analysis. Blood, urine, stool routine lab tests (including metabolic and inflammatory markers such as fasting blood glucose, fasting triglycerides, albumin, creatinine, glucose, C-reactive protein, white blood cell count, etc.) and biological sample collection will also be performed for these patients.
Eligible participants who have never experienced symptoms of urinary incontinence and have no chronic comorbidity (expect for well-controlled hypertension and hyperlipidemia) and are not taking medications that affect urination or gut microbiota will serve as healthy controls. For healthy group, only blood, urine, stool routine lab tests and bio-sample will be conducted.
All data will be independently collected and cross-verified by two researchers, and entered into the electronic data management system (REDCap).
- Conditions
- Urinary Incontinence in Old Age
- Keywords
- urinary incontinence, female
- Medical subject headings
- Urinary Incontinence
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Stress Urinary Incontinence (SUI) | Women diagnosed with SUI per EAU and ICS criteria: involuntary leakage during increased intra-abdominal pressure (e.g., exertion, coughing), stopping when the activity ends. Confirmed by positive cough stress or 1-hour pad test (>1g leakage), and bladder diary showing stress-only leakage. Initial screening uses the Chinese 3IQ, option A ("leakage with physical activity"). Cases with urge or mixed symptoms are excluded. No intervention to be administered. | |
| Urge Urinary Incontinence (UUI) | Women diagnosed with UUI per EAU and ICS criteria: involuntary leakage of urine accompanied by or immediately preceded by urgency. Preliminary screening with Chinese 3IQ, option B ("leakage with urgency"). Final diagnosis confirmed by a bladder diary showing urgency-only leakage. Cases with stress or mixed symptoms are excluded. No intervention to be administered. | |
| Mixed Urinary Incontinence (MUI) | Women diagnosed with MUI per EAU and ICS guidelines: symptoms of both stress and urge urinary incontinence. Confirmed by positive 1-hour pad test (>1g) and bladder diary showing both stress- and urgency-related leakage. Preliminary screening with Chinese 3IQ, option D ("leakage equally with activity and urgency"). Cases with pure stress or urge incontinence excluded. No intervention to be administered. | |
| Healthy Volunteers (HC) | Female volunteers aged ≥55, living in Hong Kong ≥1 year, no history or symptoms of urinary incontinence, no recent urological consultation, and no major comorbidities (except well-controlled hypertension/hyperlipidemia). Not using drugs affecting urination or the gut microbiota. Able to understand instructions and provide consent. Exclusions: UI diagnosis, involuntary urine leakage, severe illness interfering with assessment. No intervention to be administered. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence of each urinary incontinence (UI) subtype (SUI, UUI, MUI) among older women with UI in Hong Kong
Percentage of participants diagnosed with SUI, UUI, or MUI, determined by standardized clinical assessment (1-hour pad test, bladder diary, ICS/EAU criteria).
Measured: Baseline visit and 1-week diaries
Distribution of Severity among UI Patients
Proportion of UI patients classified as mild, moderate, or severe according to the Sandvik Severity Index and results of the 1-hour pad test.
Measured: Baseline visit and 1-week diaries
Distribution of TCM Syndromes
Classification of TCM syndromes identified through standardized symptom and sign assessment, using consensus or statistical grouping approaches.
Measured: Baseline visit
Biomarker Profiles and Their Associations with Clinical Features in UI Patients and Healthy Controls
Measurement of laboratory and -omics biomarkers in blood, urine, and stool samples of UI patients (by subtype and severity) and healthy controls
Measured: Baseline biosample collection
Secondary outcomes (4)
Urinary Incontinence Knowledge Score
Assessment of UI knowledge using the Urinary Incontinence Questionnaire (UIQ) in patients and healthy controls.
Measured: Baseline assessment
Barriers to Incontinence Care Seeking
Barriers to Incontinence Care Seeking Questionnaire (BICS-Q) total and subscale scores.
Measured: Baseline assessment
Quality of Life Scores (IIQ-7, ICIQ-UI-SF)
Patient-reported impact of urinary incontinence on daily life measured with the Incontinence Impact Questionnaire-7 (IIQ-7) and International Consultation on Incontinence Questionnaire Urinary Incontinence Short Form (ICIQ-UI-SF).
Measured: Baseline assessment
Hand Grip Strength
Hand grip strength measurement in UI patients and healthy controls.
Measured: Baseline assessment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Nov 2025
- Study start30 Nov 2025 (estimated)
- Primary completion1 Dec 2026 (estimated)
- Study completion1 Mar 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Urinary Incontinence in Old AgeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 1,100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hong Kong Baptist University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, ZhaoXiang Bian, Hong Kong Baptist University
- Investigators
- Qianqian Xu, MS, RCMP, Study director, Vincent V.C. Woo Chinese Medicine Clinical Research Institute, Hong Kong Baptist University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07243223
- Sponsor's protocol ID
- REC/24-25/0631
- Acronym
- PROMOTE
- Status last verified
- Nov 2025
- First submitted
- 17 Nov 2025
- Last updated
- 21 Nov 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 21 Nov 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Epidemiological Profiles, Traditional Chinese Medicine Syndrome, and Biomarkers of Urinary Incontinence in Older Hong Kong Women: A Cross-sectional Study
- ClinicalTrials.gov ID
- NCT07243223
- Acronym / sponsor ID
- PROMOTE / REC/24-25/0631
- Conditions
- Urinary Incontinence in Old Age
- Keywords
- urinary incontinence, female
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 1,100 participants (estimated)
- Lead sponsor
- Hong Kong Baptist UniversityUniversity, hospital or other
- Study start
- 30 Nov 2025 (estimated)
- Primary completion
- 1 Dec 2026 (estimated)
- Study completion
- 1 Mar 2027 (estimated)
- First posted
- 21 Nov 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a prospective, cross-sectional study aim to include 1000 patients with urinary incontinence and 100 healthy controls in Hong Kong. The overall objection is to address the gaps in epidemiological profiles, TCM syndrome differentiation, and biomarkers discovery of urinary incontinence among older women. The specific aims including:
- To assess the epidemiological characteristics of urinary incontinence among older women, as well as patients' knowledge and healthcare-seeking barriers, and to explore factors influencing the disease subtypes, severity, and healthcare-seeking behaviors;
- To establish diagnostic criteria for traditional Chinese medicine (TCM) syndrome differentiation of urinary incontinence, and analyze the distribution of TCM syndromes;
- To explore diagnostic biomarkers and severity evaluation biomarkers for three subtypes of urinary incontinence (SUI, UUI, MUI).
Detailed description
This study is a cross-sectional observational study designed in accordance with the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines. A total of 1,000 female patients with urinary incontinence and 100 healthy controls will be enrolled.
Both urinary incontinence group and healthy group will be recruited through a combination of online publicity (via social media platforms) and offline community outreach. Each participant will be scheduled for a visit, during which the research staff will introduce the study's objectives, procedures, nature, and data privacy policy. Informed consent will be obtained. Socio-epi-demographic information (including age, educational level, marital status, occupation, income, reproductive history, medical history, comorbidities, medication history, diagnosis and treatment for urinary incontinence) and the type, frequency and severity of lower urinary tract symptoms will be collected.
Then, eligible participants with symptoms of urinary incontinence will undergo a 1-hour pad test, bladder capacity and post-void residual volume measurements, and a 1-week bladder diary to confirm the subtype of urinary incontinence (SUI, MUI, UUI) and its severity (mild, moderate, severe). Standardized questionnaires will be administered to assess the cognitive level regarding urinary incontinence (UIQ), quality of life (IIQ-7 and ICIQ-UI-SF), and barriers to care seeking (Barriers to Incontinence Care Seeking Questionnaire). Hand grip strength test will be conducted to evaluate the muscle strength. The first 300 urinary incontinence patients (100 with SUI, 100 with UUI, and 100 with MUI) enrolled in the study, who do not have chronic comorbidities (except for well-controlled hypertension or hyperlipidemia) and are not taking medications that affect urination or gut microbiota, will proceed to TCM syndrome differentiation and bio-sample collection. TCM syndrome differentiation related symptoms and signs will be collected for Delphi consensus research and cluster analysis. Blood, urine, stool routine lab tests (including metabolic and inflammatory markers such as fasting blood glucose, fasting triglycerides, albumin, creatinine, glucose, C-reactive protein, white blood cell count, etc.) and biological sample collection will also be performed for these patients.
Eligible participants who have never experienced symptoms of urinary incontinence and have no chronic comorbidity (expect for well-controlled hypertension and hyperlipidemia) and are not taking medications that affect urination or gut microbiota will serve as healthy controls. For healthy group, only blood, urine, stool routine lab tests and bio-sample will be conducted.
All data will be independently collected and cross-verified by two researchers, and entered into the electronic data management system (REDCap).
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Stress Urinary Incontinence (SUI) | – | –Women diagnosed with SUI per EAU and ICS criteria: involuntary leakage during increased intra-abdominal pressure (e.g., exertion, coughing), stopping when the activity ends. Confirmed by positive cough stress or 1-hour pad test (>1g leakage), and bladder diary showing stress-only leakage. Initial screening uses the Chinese 3IQ, option A ("leakage with physical activity"). Cases with urge or mixed symptoms are excluded. No intervention to be administered. |
| Urge Urinary Incontinence (UUI) | – | –Women diagnosed with UUI per EAU and ICS criteria: involuntary leakage of urine accompanied by or immediately preceded by urgency. Preliminary screening with Chinese 3IQ, option B ("leakage with urgency"). Final diagnosis confirmed by a bladder diary showing urgency-only leakage. Cases with stress or mixed symptoms are excluded. No intervention to be administered. |
| Mixed Urinary Incontinence (MUI) | – | –Women diagnosed with MUI per EAU and ICS guidelines: symptoms of both stress and urge urinary incontinence. Confirmed by positive 1-hour pad test (>1g) and bladder diary showing both stress- and urgency-related leakage. Preliminary screening with Chinese 3IQ, option D ("leakage equally with activity and urgency"). Cases with pure stress or urge incontinence excluded. No intervention to be administered. |
| Healthy Volunteers (HC) | – | –Female volunteers aged ≥55, living in Hong Kong ≥1 year, no history or symptoms of urinary incontinence, no recent urological consultation, and no major comorbidities (except well-controlled hypertension/hyperlipidemia). Not using drugs affecting urination or the gut microbiota. Able to understand instructions and provide consent. Exclusions: UI diagnosis, involuntary urine leakage, severe illness interfering with assessment. No intervention to be administered. |
Who may qualify
- Ages
- 55 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Urinary incontinence group: Aged ≥55 years; Has been living in Hong Kong for one year or more; Meet the diagnostic criteria for MUI, UUI, or MUI defined by the International Continence Society (ICS); Able to understand and use Chinese or English; Signed the informed consent form. Healthy group: Aged ≥55 years; Has been living in Hong Kong for one year or more; Never went through urinary incontinence and never consult the doctor for suspect urinary incontinence related symptoms; No chronic comorbidity (expect for well-controlled hypertension and hyperlipidemia); Not taking medications that affect urination or gut microbiota; Able to understand and use Chinese or English; Signed the informed consent form.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Prevalence of each urinary incontinence (UI) subtype (SUI, UUI, MUI) among older women with UI in Hong Kong
Time frame: Baseline visit and 1-week diaries
Percentage of participants diagnosed with SUI, UUI, or MUI, determined by standardized clinical assessment (1-hour pad test, bladder diary, ICS/EAU criteria).
Distribution of Severity among UI Patients
Time frame: Baseline visit and 1-week diaries
Proportion of UI patients classified as mild, moderate, or severe according to the Sandvik Severity Index and results of the 1-hour pad test.
Distribution of TCM Syndromes
Time frame: Baseline visit
Classification of TCM syndromes identified through standardized symptom and sign assessment, using consensus or statistical grouping approaches.
Biomarker Profiles and Their Associations with Clinical Features in UI Patients and Healthy Controls
Time frame: Baseline biosample collection
Measurement of laboratory and -omics biomarkers in blood, urine, and stool samples of UI patients (by subtype and severity) and healthy controls
4 secondary outcomes
Urinary Incontinence Knowledge Score
Time frame: Baseline assessment
Barriers to Incontinence Care Seeking
Time frame: Baseline assessment
Quality of Life Scores (IIQ-7, ICIQ-UI-SF)
Time frame: Baseline assessment
Hand Grip Strength
Time frame: Baseline assessment
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Nov 2025.
- Individual participant dataSharing planned: Undecided
Related trials for Urinary Incontinence in Old Age
RecruitingPhase 1
Allogeneic Use of Expanded Mesenchymal Stem Cells Derived From Adipose Tissue (HC106), Female Urinary Incontinence Women Over 50 Years Old
Urinary Incontinence Stress
RecruitingObservational study
URINARY INCONTINENCE AND GERIATRIC SYNDROMES
Urinary Incontinence (UI), Urinary Incontinence
Recruiting
Effects of Action Observation and Metaphorical Imagery in Pelvic Floor Muscle Training for Geriatric Urinary Incontinence
Urinary Continence
Enrolling by invitationObservational study
Validity and Reliability of the Turkish Form of the Knowledge Assessment Scales for Dementia and Urinary Incontinence
Urinary Incontinence in Old Age, Dementia
Active, not recruitingPhase 1/2
Reduced-dose Botox for Urgency Incontinence Among Elder Females
Overactive Bladder, Urinary Incontinence in Old Age
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Qianqian Xu, MS, RCMP study director
Vincent V.C. Woo Chinese Medicine Clinical Research Institute, Hong Kong Baptist University
Questions about this trial
What is this clinical trial studying?
An observational study of Urinary Incontinence in Old Age, run by Hong Kong Baptist University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 21 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact ZhaoXiang Bian, Prof. (852-34116521, bzxiang@hkbu.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence of each urinary incontinence (UI) subtype (SUI, UUI, MUI) among older women with UI in Hong Kong (time frame: Baseline visit and 1-week diaries). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Nov 2025.